Penumbra Inc (PEN) stock forecast · P/E 237, rev $764.8M
Penumbra Inc (PEN) is a medical devices company listed on US.
This PEN forecast page states what the cached financials imply — not a price target and not a guarantee. Penumbra Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported PEN revenue for 2026-06-30 was $764.8M. Net income was $67.4M. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
Period-over-period revenue change is not in cache for PEN, so this page does not invent a growth rate.
PEN currently screens at market cap $9.93B and trailing P/E 237.4. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next PEN 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the PEN stock page.
Not investment advice.